Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
669 | 12548 | 32.0 | 71% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
123 | 65775 | CONTACT DERMATITIS//DERMATOLOGY//PSORIASIS |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PSORIASIS | Author keyword | 2225 | 53% | 23% | 2939 |
2 | PSORIATIC ARTHRITIS | Author keyword | 621 | 54% | 6% | 798 |
3 | CALCIPOTRIOL | Author keyword | 138 | 66% | 1% | 128 |
4 | USTEKINUMAB | Author keyword | 110 | 67% | 1% | 100 |
5 | PSORIASIS AREA AND SEVERITY INDEX | Author keyword | 108 | 83% | 0% | 60 |
6 | EFALIZUMAB | Author keyword | 88 | 66% | 1% | 81 |
7 | DITHRANOL | Author keyword | 87 | 66% | 1% | 80 |
8 | ALEFACEPT | Author keyword | 81 | 80% | 0% | 51 |
9 | PSORIASIS VULGARIS | Author keyword | 81 | 47% | 1% | 129 |
10 | ETANERCEPT | Author keyword | 73 | 22% | 2% | 291 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PSORIASIS | 2225 | 53% | 23% | 2939 | Search PSORIASIS | Search PSORIASIS |
2 | PSORIATIC ARTHRITIS | 621 | 54% | 6% | 798 | Search PSORIATIC+ARTHRITIS | Search PSORIATIC+ARTHRITIS |
3 | CALCIPOTRIOL | 138 | 66% | 1% | 128 | Search CALCIPOTRIOL | Search CALCIPOTRIOL |
4 | USTEKINUMAB | 110 | 67% | 1% | 100 | Search USTEKINUMAB | Search USTEKINUMAB |
5 | PSORIASIS AREA AND SEVERITY INDEX | 108 | 83% | 0% | 60 | Search PSORIASIS+AREA+AND+SEVERITY+INDEX | Search PSORIASIS+AREA+AND+SEVERITY+INDEX |
6 | EFALIZUMAB | 88 | 66% | 1% | 81 | Search EFALIZUMAB | Search EFALIZUMAB |
7 | DITHRANOL | 87 | 66% | 1% | 80 | Search DITHRANOL | Search DITHRANOL |
8 | ALEFACEPT | 81 | 80% | 0% | 51 | Search ALEFACEPT | Search ALEFACEPT |
9 | PSORIASIS VULGARIS | 81 | 47% | 1% | 129 | Search PSORIASIS+VULGARIS | Search PSORIASIS+VULGARIS |
10 | ETANERCEPT | 73 | 22% | 2% | 291 | Search ETANERCEPT | Search ETANERCEPT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHRONIC PLAQUE PSORIASIS | 740 | 75% | 4% | 538 |
2 | PLAQUE PSORIASIS | 338 | 64% | 3% | 331 |
3 | TO SEVERE PSORIASIS | 296 | 79% | 2% | 189 |
4 | SEVERE PLAQUE PSORIASIS | 237 | 75% | 1% | 172 |
5 | INTERLEUKIN 12 23 MONOCLONAL ANTIBODY | 202 | 57% | 2% | 243 |
6 | PLAQUE TYPE PSORIASIS | 200 | 72% | 1% | 159 |
7 | FAMILIAL PSORIASIS | 183 | 87% | 1% | 89 |
8 | PSORIASIS | 164 | 18% | 7% | 821 |
9 | INFLIXIMAB INDUCTION | 158 | 91% | 1% | 67 |
10 | CALCIPOTRIOL | 120 | 57% | 1% | 142 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF DERMATOLOGICAL TREATMENT | 55 | 20% | 2% | 245 |
2 | ACTA DERMATO-VENEREOLOGICA | 48 | 10% | 4% | 449 |
3 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 48 | 12% | 3% | 381 |
4 | ARCHIVES OF DERMATOLOGICAL RESEARCH | 43 | 11% | 3% | 375 |
5 | PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE | 14 | 11% | 1% | 127 |
6 | JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 13 | 13% | 1% | 94 |
7 | AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | 9 | 11% | 1% | 73 |
8 | SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY | 3 | 10% | 0% | 29 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence | 2013 | 142 | 52 | 83% |
Mechanisms of Disease: Psoriasis. | 2009 | 668 | 88 | 75% |
Psoriatic arthritis: current therapy and future approaches | 2015 | 5 | 51 | 82% |
PASI90 response: the new standard in therapeutic efficacy for psoriasis | 2015 | 4 | 17 | 94% |
Pathogenesis and therapy of psoriasis | 2007 | 620 | 60 | 68% |
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies | 2012 | 139 | 70 | 63% |
European S3-Guidelines on the systemic treatment of psoriasis vulgaris | 2009 | 224 | 211 | 81% |
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics | 2008 | 290 | 154 | 75% |
Immunology of Psoriasis | 2014 | 40 | 128 | 44% |
Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials | 2014 | 16 | 65 | 94% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PSORIASIS | 83 | 82% | 0.4% | 49 |
2 | PSORIAT ARTHRIT PROGRAM | 72 | 79% | 0.4% | 46 |
3 | PROGNOSIS STUDIES RHEUMAT DIS | 46 | 38% | 0.8% | 95 |
4 | PSORIAT ARTHRIT CLIN | 36 | 77% | 0.2% | 24 |
5 | MURDOUGH FAMILY PSORIASIS | 28 | 68% | 0.2% | 25 |
6 | INVEST DERMATOL | 27 | 37% | 0.5% | 58 |
7 | PSORIASIS ZENTRUM | 24 | 91% | 0.1% | 10 |
8 | INSERM CRO2 | 23 | 86% | 0.1% | 12 |
9 | CDR ST ANTOINE HOSP | 20 | 100% | 0.1% | 9 |
10 | COCHIN TARNIER HOSP | 20 | 100% | 0.1% | 9 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000017868 | ATOPIC DERMATITIS//ITCH//MALASSEZIA |
2 | 0.0000012372 | RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL |
3 | 0.0000011635 | FIBRILLARY GLOMERULONEPHRITIS//NAIL PATELLA SYNDROME//YELLOW NAIL SYNDROME |
4 | 0.0000011518 | EXTRACORPOREAL PHOTOCHEMOTHERAPY//PHOTOPHERESIS//EXTRACORPOREAL PHOTOPHERESIS |
5 | 0.0000010216 | VESTNIK DERMATOLOGII I VENEROLOGII//BRCN ACTIVATED SEPHAROSE//CURANTIL |
6 | 0.0000009922 | SUNSCREENS//UV FILTERS//PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE |
7 | 0.0000008980 | ANKYLOSING SPONDYLITIS//HLA B27//SPONDYLOARTHRITIS |
8 | 0.0000008040 | GRANULOMA ANNULARE//NECROBIOSIS LIPOIDICA//MOLLUSCUM CONTAGIOSUM |
9 | 0.0000006768 | ACNE VULGARIS//ACNE//ROSACEA |
10 | 0.0000006349 | SKIN RESEARCH AND TECHNOLOGY//STRATUM CORNEUM//TRANSEPIDERMAL WATER LOSS |